Clearwater International advises mic on sale of neuroConn to NeuroCare Group

Clearwater International acted as sole financial adviser to mic AG and its co-shareholders on the sale of 90.55% of the outstanding shares in neuroConn GmbH (“neuroConn”) to NeuroCare Group, owned by a consortium of investors led by Passion Investment Group (Australia).

neuroConn, founded 2005 in Ilmenau (Germany), is the leading specialist focused on the development of best-in-class medical instruments and complete systems for non-invasive treatments of severe neurological & psychiatric diseases and the world's first supplier of complete, certified, multi-channel EEG feedback devices for neurofeedback of slow cortical potentials (SCP-Feedback).

neuroConn is active in the fast growing, multibillion USD market for neurostimulation. With its DC-STIMULATOR products, the company offers a highly innovative, validated and certified transcranial Direct Current Stimulation based non-invasive treatment method for e.g. depression, stroke, migraine or tinnitus etc.

As a venture capitalist, Munich-based mic AG invests at an early stage in promising companies in the clean-tech, life sciences, microsystems, optics and software/IT sectors.

  • Image of mic AG Company Logo
    Image of neuroConn GmbH Company Logo
    Image of NeuroCare Group GmbH Company Logo
    View Back of Transaction
    Clearwater Advisers

    Adviser to mic AG on its sale of neuroConn GmbH to NeuroCare Group GmbH

    View more